Skip to main content

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.


  • Brittany Meyer participating as a healthy control in a clinical trial.

    My Experience as a Healthy Participant in a Clinical Trial

    Senior Associate Director of Public Policy, Brittany Meyer, details her experience participating in a clinical trial at the NIH.
    Learn more

  • Todd Sherer on stage at PDTC 2019.

    Highlights from Our 13th Parkinson’s Disease Therapeutics Conference

    On October 15, our CEO Todd Sherer, PhD, welcomed more than 300 leaders to the annual conference in New York.
    Learn more

  • Head shot of Dr. Tim Greenamyre.

    New Findings Bolster Case for Parkinson’s Therapies Targeting LRRK2

    Recent findings suggest LRRK2 kinase inhibitors may benefit a broad array of patients.
    Learn more

  • Close up of hand holding test tube

    Second Chance for a Once-“failed” Alzheimer’s Drug

    Today, in what has been deemed a “shock move” by some media reports, aducanamab is back on the map.
    Learn more

  • Ask the PhD: Immune System’s Role in Parkinson’s Disease

    Scientists discuss how inflammation could harm cells and what researchers are doing to better define, measure, and treat this Parkinson’s pathway.
    Learn more

  • Default content image

    ASAP Initiative Launches First Funding Opportunity

    ASAP seeks to support international, multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic disease mechanisms that contribute to Parkinson’s development and…
    Learn more

Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.